Report Detail
Biopharmaceutical Contract Manufacturing Market to 2027 - Global Analysis and Forecasts by Product (Biologics, Biosimilars); Service (Development Process, Final Dosage Operation, Analytical and Quality Control, Final Packaging), and Geography
- RnM3946163 |
- 10 April, 2020 |
- Global |
- 174 Pages |
- The Insight Partners |
- Pharma & Healthcare
The biopharmaceuticals contract manufacturing market was valued at US$ 13,727.13 million in 2019 and is expected to grow at a CAGR of 8.2% from 2020 to 2027 to reach US$ 25,497.26 million by 2027.
Driving factors of the biopharmaceuticals contract manufacturing market are increasing trend of outsourcing among pharmaceuticals companies and elevating demand for biologics. However, growing competition in biopharmaceutical contract manufacturing industry is hindering the growth of the market.
The contract manufacturing organization (CMO) offers numerous benefits, including reducing investments in facilities and drug development costs, to pharmaceutical companies, thereby improving net cash flow. Outsourcing is cheaper and increases the efficiency of manufacturing processes. Also, it allows pharmaceutical and biotechnology companies to redirect resources to other areas. A few years ago, the CMO industry was a niche service market, offering additional manufacturing capacity or specific services to pharmaceutical companies. Presently, many pharmaceuticals and biotechnology companies outsource various services from early-stage drug development to commercial-scale manufacturing. As the pharmaceuticals industry is shifting from large-scale production to more niche and targeted therapies (personalized medicine), the demand for flexible operational capabilities, production scales, and multiple-product operations is leading to the rise in inclination toward CMOs.
The global biopharmaceuticals contract manufacturing market is segmented into product and services. The biopharmaceuticals contract manufacturing market, by product, is segmented into biologics and biosimilars. The biologics segment held the largest share of the market in 2019, whereas the biosimilar segment is anticipated to register the highest CAGR in the market during the forecast period. Based on services, the market is segmented into development process, final dosage operations, and final packaging. The development process held the largest share of the market in 2019, whereas analytical and quality control segment is estimated to register the highest CAGR in the market during the forecast period.
Some of the essential primary and secondary sources included in the report are The Pharma & Biopharma Outsourcing Association (PBOA), Centers for Disease Control and Prevention, and Organization for Economic Co-operation and Development.
TABLE OF CONTENTS
1. Introduction
- 1.1 Study Scope
- 1.2 The Insight Partners Research Report Guidance
- 1.3 Market Segmentation
- 1.3.1 Global Biopharmaceutical Contract Manufacturing Market – By Product
- 1.3.2 Global Biopharmaceutical Contract Manufacturing Market – By Service
- 1.3.3 Global Biopharmaceutical Contract Manufacturing Market – By Geography
2. Biopharmaceutical Contract Manufacturing Market – Key Takeaways
3. Research Methodology
- 3.1 Coverage
- 3.2 Secondary Research
- 3.3 Primary Research
4. Biopharmaceutical Contract Manufacturing – Market Landscape
- 4.1 Overview
- 4.2 PEST Analysis
- 4.2.1 North America – PEST Analysis
- 4.2.2 Europe – PEST Analysis
- 4.2.3 Asia Pacific – PEST Analysis
- 4.2.4 Middle East and Africa (MEA) – PEST Analysis
- 4.2.5 South and Central America – PEST Analysis
- 4.3 Expert Opinion
5. Biopharmaceuticals Contract Manufacturing Market – Industry Dynamics
- 5.1 Key Drivers
- 5.1.1 Increasing Outsourcing by Pharmaceutical Companies
- 5.1.2 Increasing Demand of Biologics
- 5.2 Key Market Restraints
- 5.2.1 Increasing Competition in the Industry
- 5.3 Key Market Opportunities
- 5.3.1 Emerging Markets
- 5.4 Future Trends
- 5.4.1 Consolidation in Pharmaceutical CMO Industry
- 5.5 Impact Analysis
6. Biopharmaceutical Contract Manufacturing Market – Global Analysis
- 6.1 Global Biopharmaceutical Contract Manufacturing Market Revenue Forecast And Analysis
- 6.2 Global Biopharmaceutical Contract Manufacturing Market, By Geography - Forecast And Analysis
- 6.3 Market Positioning of Key Players
- 6.3.1 Lonza Group AG
- 6.3.2 Thermo Fisher Scientific, Inc.
7. Biopharmaceuticals Contract Manufacturing Market Analysis – By Product
- 7.1 Overview
- 7.2 Biopharmaceuticals Contract Manufacturing Market Revenue Share, by Product (2019 and 2027)
- 7.3 Biologics
- 7.3.1 Overview
- 7.3.2 Biologics: Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2027 (US$ Million)
- 7.3.3 Monoclonal Antibodies
- 7.3.3.1 Overview
- 7.3.3.2 Monoclonal Antibodies: Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2027 (US$ Million)
- 7.3.4 Recombinant Proteins
- 7.3.4.1 Overview
- 7.3.4.2 Recombinant Proteins: Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2027 (US$ Million)
- 7.3.5 Vaccines
- 7.3.5.1 Overview
- 7.3.5.2 Vaccines: Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2027 (US$ Million)
- 7.3.6 Others
- 7.3.6.1 Overview
- 7.3.7 Others: Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2027 (US$ Million)
- 7.4 Biosimilars
- 7.4.1 Overview
- 7.4.2 Biosimilars: Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2027 (US$ Million)
8. Biopharmaceuticals Contract Manufacturing Market – By Service
- 8.1 Overview
- 8.2 Biopharmaceuticals Contract Manufacturing Market, by Service, 2019 and 2027 (%)
- 8.3 Development Process
- 8.3.1 Overview
- 8.3.2 Development Process: Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2027 (US$ Million)
- 8.4 Final Dosage Operation
- 8.4.1 Overview
- 8.4.2 Final Dosage Operation: Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2027 (US$ Million)
- 8.5 Analytical and Quality Control
- 8.5.1 Overview
- 8.5.2 Analytical and Quality Control: Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2027 (US$ Million)
- 8.6 Final Packaging
- 8.6.1 Overview
- 8.6.2 Final Packaging: Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2027 (US$ Million)
9. Biopharmaceutical Contract Manufacturing Market – Geographic Analysis
- 9.1 North America: Biopharmaceutical Contract Manufacturing Market
- 9.1.1 Overview
- 9.1.2 North America: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
- 9.1.3 North America: Biopharmaceutical Contract Manufacturing Market, by Product, 2018–2027 (USD Million)
- 9.1.3.1 North America: Biologics Market, by Type, 2018–2027 (USD Million)
- 9.1.4 North America: Biopharmaceutical Contract Manufacturing Market, by Service, 2018–2027 (USD Million)
- 9.1.5 North America: Biopharmaceutical Contract Manufacturing Market, by Country, 2019 & 2027 (%)
- 9.1.6 US: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
- 9.1.6.1 US: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
- 9.1.6.2 US: Biopharmaceutical Contract Manufacturing Market, by Product, 2018–2027 (USD Million)
- 9.1.6.2.1 US: Biologics Market, by Type, 2018–2027 (USD Million)
- 9.1.6.3 US: Biopharmaceutical Contract Manufacturing Market, by Service, 2018–2027 (USD Million)
- 9.1.7 Canada: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
- 9.1.7.1 Canada: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
- 9.1.7.2 Canada: Biopharmaceutical Contract Manufacturing Market, by Product, 2018–2027 (USD Million)
- 9.1.7.2.1 Canada: Biologics Market, by Type, 2018–2027 (USD Million)
- 9.1.7.3 Canada: Biopharmaceutical Contract Manufacturing Market, by Service, 2018–2027 (USD Million)
- 9.1.8 Mexico: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
- 9.1.8.1 Mexico: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
- 9.1.8.2 Mexico: Biopharmaceutical Contract Manufacturing Market, by Product, 2018–2027 (USD Million)
- 9.1.8.2.1 Mexico: Biologics Market, by Type, 2018–2027 (USD Million)
- 9.1.8.3 Mexico: Biopharmaceutical Contract Manufacturing Market, by Service, 2018–2027 (USD Million)
- 9.2 Europe: Biopharmaceutical Contract Manufacturing Market
- 9.2.1 Overview
- 9.2.2 Europe: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
- 9.2.3 Europe: Biopharmaceutical Contract Manufacturing Market, by Product, 2018–2027 (USD Million)
- 9.2.3.1 Europe: Biologics Market, by Type, 2018–2027 (USD Million)
- 9.2.4 Europe: Biopharmaceutical Contract Manufacturing Market, by Service, 2018–2027 (USD Million)
- 9.2.5 Europe: Biopharmaceutical Contract Manufacturing Market, by Country, 2019 & 2027 (%)
- 9.2.6 Germany: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
- 9.2.6.1 Germany: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
- 9.2.6.2 Germany: Biopharmaceutical Contract Manufacturing Market, by Product, 2018–2027 (USD Million)
- 9.2.6.2.1 Germany: Biologics Market, by Type, 2018–2027 (USD Million)
- 9.2.7 Germany: Biopharmaceutical Contract Manufacturing Market, by Service, 2018–2027 (USD Million)
- 9.2.8 UK: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
- 9.2.8.1 UK: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
- 9.2.8.2 UK: Biopharmaceutical Contract Manufacturing Market, by Product, 2018–2027 (USD Million)
- 9.2.8.2.1 UK: Biologics Market, by Type, 2018–2027 (USD Million)
- 9.2.8.3 UK: Biopharmaceutical Contract Manufacturing Market, by Service, 2018–2027 (USD Million)
- 9.2.9 France: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
- 9.2.9.1 France: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
- 9.2.9.2 France: Biopharmaceutical Contract Manufacturing Market, by Product, 2018–2027 (USD Million)
- 9.2.9.2.1 France: Biologics Market, by Type, 2018–2027 (USD Million)
- 9.2.9.3 France: Biopharmaceutical Contract Manufacturing Market, by Service, 2018–2027 (USD Million)
- 9.2.10 Spain: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
- 9.2.10.1 Spain: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
- 9.2.10.2 Spain: Biopharmaceutical Contract Manufacturing Market, by Product, 2018–2027 (USD Million)
- 9.2.10.2.1 Spain: Biologics Market, by Type, 2018–2027 (USD Million)
- 9.2.10.3 Spain: Biopharmaceutical Contract Manufacturing Market, by Service, 2018–2027 (USD Million)
- 9.2.11 Italy: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
- 9.2.11.1 Italy: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
- 9.2.11.2 Italy: Biopharmaceutical Contract Manufacturing Market, by Product, 2018–2027 (USD Million)
- 9.2.11.2.1 Italy: Biologics Market, by Type, 2018–2027 (USD Million)
- 9.2.11.3 Italy: Biopharmaceutical Contract Manufacturing Market, by Service, 2018–2027 (USD Million)
- 9.3 Asia Pacific: Biopharmaceutical Contract Manufacturing Market
- 9.3.1 Overview
- 9.3.2 Asia Pacific: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
- 9.3.3 Asia Pacific: Biopharmaceutical Contract Manufacturing Market, by Product, 2018–2027 (USD Million)
- 9.3.3.1 Asia Pacific: Biologics Market, by Type, 2018–2027 (USD Million)
- 9.3.4 Asia Pacific: Biopharmaceutical Contract Manufacturing Market, by Service, 2018–2027 (USD Million)
- 9.3.5 Asia Pacific: Biopharmaceutical Contract Manufacturing Market, by Country, 2019 & 2027 (%)
- 9.3.6 China: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
- 9.3.6.1 China: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
- 9.3.6.2 China: Biopharmaceutical Contract Manufacturing Market, by Product, 2018–2027 (USD Million)
- 9.3.6.2.1 China: Biologics Market, by Type, 2018–2027 (USD Million)
- 9.3.6.3 China: Biopharmaceutical Contract Manufacturing Market, by Service, 2018–2027 (USD Million)
- 9.3.7 Japan: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
- 9.3.7.1 Japan: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
- 9.3.7.2 Japan: Biopharmaceutical Contract Manufacturing Market, by Product, 2018–2027 (USD Million)
- 9.3.7.2.1 Japan: Biologics Market, by Type, 2018–2027 (USD Million)
- 9.3.7.3 Japan: Biopharmaceutical Contract Manufacturing Market, by Service, 2018–2027 (USD Million)
- 9.3.8 India: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
- 9.3.8.1 India: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
- 9.3.8.2 India: Biopharmaceutical Contract Manufacturing Market, by Product, 2018–2027 (USD Million)
- 9.3.8.2.1 India: Biologics Market, by Type, 2018–2027 (USD Million)
- 9.3.8.3 India: Biopharmaceutical Contract Manufacturing Market, by Service, 2018–2027 (USD Million)
- 9.3.9 South Korea: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
- 9.3.9.1 South Korea: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
- 9.3.9.2 South Korea: Biopharmaceutical Contract Manufacturing Market, by Product, 2018–2027 (USD Million)
- 9.3.9.2.1 South Korea: Biologics Market, by Type, 2018–2027 (USD Million)
- 9.3.9.3 South Korea: Biopharmaceutical Contract Manufacturing Market, by Service, 2018–2027 (USD Million)
- 9.3.10 Australia: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
- 9.3.10.1 Australia: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
- 9.3.10.2 Australia: Biopharmaceutical Contract Manufacturing Market, by Product, 2018–2027 (USD Million)
- 9.3.10.2.1 Australia: Biologics Market, by Type, 2018–2027 (USD Million)
- 9.3.10.3 Australia: Biopharmaceutical Contract Manufacturing Market, by Service, 2018–2027 (USD Million)
- 9.4 Middle East & Africa: Biopharmaceutical Contract Manufacturing Market
- 9.4.1 Overview
- 9.4.2 Middle East & Africa: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
- 9.4.3 Middle East & Africa: Biopharmaceutical Contract Manufacturing Market, by Product, 2018–2027 (USD Million)
- 9.4.3.1 Middle East & Africa: Biologics Market, by Type, 2018–2027 (USD Million)
- 9.4.4 Middle East & Africa: Biopharmaceutical Contract Manufacturing Market, by Service, 2018–2027 (USD Million)
- 9.4.5 Middle East & Africa: Biopharmaceutical Contract Manufacturing Market Share by Country – 2019 & 2027, (%)
- 9.4.6 Saudi Arabia: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
- 9.4.6.1 Saudi Arabia: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
- 9.4.6.2 Saudi Arabia: Biopharmaceutical Contract Manufacturing Market, by Product, 2018–2027 (USD Million)
- 9.4.6.2.1 Saudi Arabia: Biologics Market, by Type, 2018–2027 (USD Million)
- 9.4.6.3 Saudi Arabia: Biopharmaceutical Contract Manufacturing Market, by Service, 2018–2027 (USD Million)
- 9.4.7 UAE: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
- 9.4.7.1 UAE: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
- 9.4.7.2 UAE: Biopharmaceutical Contract Manufacturing Market, by Product, 2018–2027 (USD Million)
- 9.4.7.2.1 UAE: Biologics Market, by Type, 2018–2027 (USD Million)
- 9.4.7.3 UAE: Biopharmaceutical Contract Manufacturing Market, by Service, 2018–2027 (USD Million)
- 9.4.8 South Africa: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2027 (US$ Million)
- 9.4.8.1 South Africa: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
- 9.4.8.2 South Africa: Biopharmaceutical Contract Manufacturing Market, by Product, 2018–2027 (USD Million)
- 9.4.8.2.1 South Africa: Biologics Market, by Type, 2018–2027 (USD Million)
- 9.4.8.3 South Africa: Biopharmaceutical Contract Manufacturing Market, by Service, 2018–2027 (USD Million)
- 9.5 South and Central America: Biopharmaceutical Contract Manufacturing Market
- 9.5.1 Overview
- 9.5.2 South and Central America: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2027 (US$ Million)
- 9.5.3 South and Central America: Biopharmaceutical Contract Manufacturing Market, by Product, 2018–2027 (USD Million)
- 9.5.3.1 South and Central America: Biologics Market, by Type, 2018–2027 (USD Million)
- 9.5.4 South and Central America: Biopharmaceutical Contract Manufacturing Market, by Service, 2018–2027 (USD Million)
- 9.5.5 South and Central America: Biopharmaceutical Contract Manufacturing Market, by Country, 2019 & 2027 (%)
- 9.5.6 Brazil: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
- 9.5.6.1 Brazil: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
- 9.5.6.2 Brazil: Biopharmaceutical Contract Manufacturing Market, by Product, 2018–2027 (USD Million)
- 9.5.6.2.1 Brazil: Biologics Market, by Type, 2018–2027 (USD Million)
- 9.5.6.3 Brazil: Biopharmaceutical Contract Manufacturing Market, by Service, 2018–2027 (USD Million)
- 9.5.7 Argentina: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
- 9.5.7.1 Argentina: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
- 9.5.7.2 Argentina: Biopharmaceutical Contract Manufacturing Market, by Product, 2018–2027 (USD Million)
- 9.5.7.2.1 Argentina: Biologics Market, by Type, 2018–2027 (USD Million)
- 9.5.7.3 Argentina: Biopharmaceutical Contract Manufacturing Market, by Service, 2018–2027 (USD Million)
10. Impact of COVID-19 Pandemic on Biopharmaceutical Contract Manufacturing Market
- 10.1 North America: Impact assessment of COVID-19 Pandemic
- 10.2 Europe: Impact assessment of COVID-19 Pandemic
- 10.3 Asia-Pacific: Impact assessment of COVID-19 Pandemic
- 10.4 Rest of World: Impact Assessment of COVID-19 Pandemic
11. Biopharmaceutical Contract Manufacturing Market – Industry Landscape
- 11.1 Overview
- 11.2 Growth Strategies Done by the Companies in the Market, (%)
- 11.3 Organic Developments
- 11.3.1 Overview
- 11.4 Inorganic Developments
- 11.4.1 Overview
12. Company Profiles
- 12.1 Boehringer Ingelheim International GmbH
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.2 THERMO FISHER SCIENTIFIC INC.
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
- 12.3 General Electric Company
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
- 12.4 MERCK KGAA
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
- 12.5 Lonza
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
- 12.6 Samsung Biologics.
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
- 12.7 AbbVie Inc.
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
- 12.8 WUXI BIOLOGICS
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
- 12.9 Ajinomoto Co. Inc.
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
- 12.10 Inno Bio Ventures Sdn Bhd
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Products and Services
- 12.10.4 Financial Overview
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments
13. Appendix
- 13.1 About The Insight Partners
- 13.2 Glossary of Terms
Summary:
Get latest Market Research Reports on Biopharmaceutical Contract Manufacturing . Industry analysis & Market Report on Biopharmaceutical Contract Manufacturing is a syndicated market report, published as Biopharmaceutical Contract Manufacturing Market to 2027 - Global Analysis and Forecasts by Product (Biologics, Biosimilars); Service (Development Process, Final Dosage Operation, Analytical and Quality Control, Final Packaging), and Geography. It is complete Research Study and Industry Analysis of Biopharmaceutical Contract Manufacturing market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
